The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Effect of pindolol in hastening response to fluoxetine in the treatment of major depression: a double-blind, placebo-controlled trial
Abstract
OBJECTIVE: In two preliminary studies, pindolol produced robust results in hastening clinical response to antidepressant drugs in depressed patients. Validity of those pilot studies was limited by use of an open-label, unblinded study design, and so the authors conducted a double-blind, placebo-controlled trial to assess the effectiveness of pindolol in hastening response to fluoxetine. METHOD: Drug-free outpatients with major depression were concurrently treated with fluoxetine (20 mg/day) and either placebo or pindolol (5.0 mg b.i.d. or 2.5 mg t.i.d.), for 6 weeks, in a randomized, double-blind manner. After 6 weeks, all patients received fluoxetine and placebo and were followed for 3 further weeks in a single-blind manner. RESULTS: Forty-three patients completed at least 1 week of the protocol. Rates of partial remission after 2 weeks of treatment with fluoxetine and either pindolol or placebo were 17% (four of 23 patients) and 20% (four of 20 patients), respectively. At study completion, 65% of the patients (N = 28) demonstrated at least a partial remission, and there was no difference between treatment groups. The pindolol group, but not the placebo group, demonstrated significant reductions in blood pressure and pulse rate. The average time to remission and the rates of attrition, overall response, and side effects were similar in the two groups. CONCLUSIONS: These findings do not support the efficacy of pindolol in hastening clinical response in patients treated with fluoxetine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Cited by
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161
Cryan, J. F., Valentino, R. J., & Lucki, I. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.008 · Cited by 1,119
Neurobiological similarities in depression and drug dependence: a self-medication hypothesis
Markou, A. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00113-9 · Cited by 767
5-HT1A receptor function in major depressive disorder
Savitz, J., Lucki, I., & Drevets, W. C. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.01.009 · Cited by 574
Autoregulation of Serotonin Neurons: Role in Antidepressant Drug Action
Piñeyro, G., & Blier, P. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01417-0 · Cited by 537
Stockmeier, C. A., Shapiro, L. A., Dilley, G. E., Kolli, T. N., Friedman, L., & Rajkowska, G. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-18-07394.1998 · Cited by 429
Antidepressants for the new millennium
Skolnick, P. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00330-1 · Cited by 355
Blier, P. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00036-6 · Cited by 282
Australian and New Zealand Clinical Practice Guidelines for the Treatment of Depression
Royal Australian And New Zealand College Of Psychiatrists Clinical Practice Guidelines Team For Depression (2004) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/j.1440-1614.2004.01377.x · Cited by 257
Smeraldi, E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00129-8 · Cited by 116
Behavioural and biochemical studies of citalopram and WAY 100635 in rat chronic mild stress model
Papp, M., Nalepa, I., Antkiewicz-Michaluk, L., & Sánchez, C. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00778-x · Cited by 50
“However, other clinical studies have failed to show this (Berman et al., 1997; reviewed by Montgomery, 1999).”
BackgroundLiu, Y., Zhou, X., Zhu, D., Chen, J., Qin, B., Zhang, Y., Wang, X., Yang, D., Meng, H., Luo, Q., et al. (2015) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.2465 · Cited by 26
“…pindolol as a primary treatment to accelerate the antidepressant response has been assessed repeatedly over the past two decades (Maes et al., 1996; Berman et al., 1997; Perez et al., 1997; Tome et al., 1997; Zanardi et al., 1997; Bordet et al., 1998; Zanardi et al., 1998; Berman et al., 1999;…”
Background
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1997-01-01
- Volume
- 154
- Issue
- 1
- Pages
- 37-43
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2402252666
- Cited by
- 171
- References
- 1
- FWCI
- 21.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.